The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinar Eka Selaras PT
IDX:ERAL
|
ID |
|
A
|
Affinity Metals Corp
F:34IA
|
CA |
|
S
|
Steminent Biotherapeutics Inc
TPEX:7729
|
TW |
|
M
|
Modetour Network Inc
KOSDAQ:080160
|
KR |
|
S
|
S-Energy Co Ltd
KOSDAQ:095910
|
KR |
|
S
|
Solvay SA
SWB:SOL
|
BE |
|
Eagle Mountain Mining Ltd
OTC:EGMMF
|
AU |
|
P
|
Prothena Corporation PLC
F:0PT
|
IE |
|
S
|
Shanghai Chinafortune Co Ltd
SSE:600621
|
CN |
|
Fletcher King PLC
LSE:FLK
|
UK |
|
Ferrellgas Partners LP
OTC:FGPR
|
US |
|
E
|
Excel Force MSC Bhd
KLSE:EFORCE
|
MY |
|
Rakuten Group Inc
F:RAKA
|
JP |
|
Tenet Fintech Group Inc
F:P0T
|
CA |
|
AC/DC Battery Metals Inc
XTSX:ACDC
|
CA |
|
I
|
Ilya Co Ltd
KOSDAQ:058450
|
KR |
|
Focus Minerals Ltd
OTC:FCSUF
|
AU |
|
C
|
Charoen Pokphand Indonesia Tbk PT
XMUN:0CP1
|
ID |
|
L
|
Luster Industries Bhd
KLSE:LUSTER
|
MY |
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
UK |
|
Growthpoint Properties Ltd
F:G5JA
|
ZA |
|
S
|
Semperit Holding AG
F:SEW
|
AT |
|
Lithium Chile Inc
OTC:LTMCF
|
CA |
|
Ambu A/S
CSE:AMBU B
|
DK |
Sinar Eka Selaras PT (ERAL)’s 12-month stock price forecast through October 2027 has a consensus target of Rp510, implying 76% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for ERAL is 510 IDR with a low forecast of 505 IDR and a high forecast of 525 IDR.
Over the last 4 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 3 years is 18%.
Over the last 4 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.
Over the last 4 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 30%.
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 32%.
Over the last 4 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 3 years is 34%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more